Therapy Adjustment and IndividuaLized Response With Biomarker Observation in ReaL-world Heart Failure

NCT07647848 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-06-15

No results posted yet for this study

Summary

The goal of TAILOR-HF is to integrate clinical data, laboratory parameters, treatment patterns, and circulating biomarkers to identify factors that predict individual response to pharmacological treatment in patients with heart failure.

TAILOR-HF is an observational study with protocol-mandated assessments scheduled at baseline and at 1, 3, and 6 months after enrolment. Additional follow-up data will be collected through telephone visits every 6 months until the last participant has completed the protocol-mandated 6-month visit.

Conditions

Sponsors & Collaborators

  • UMCG, University Hospital (Groningen, The Netherlands)

    collaborator UNKNOWN
  • Leiden University Medical Center

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • Uniklinik RTWH Aachen

    collaborator UNKNOWN
  • Charite University, Berlin, Germany

    collaborator OTHER
  • Ospedale San Donato

    collaborator OTHER
  • Fidenza Hospital

    collaborator UNKNOWN
  • Desio Hospital

    collaborator UNKNOWN
  • Gorizia Hospital

    collaborator UNKNOWN
  • UZ Antwerpen

    collaborator UNKNOWN
  • Medizinischen Universität Wien

    collaborator UNKNOWN
  • University College Dublin

    collaborator OTHER
  • University of Ulster

    collaborator OTHER
  • University of Glasgow

    collaborator OTHER
  • Maastricht University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2028-09-01
Completion
2028-09-01

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07647848 on ClinicalTrials.gov